Summary

Market Overview
India In-vitro Fertilization Market was valued at USD 961.21 Million in 2024 and is expected to reach USD 1491.85 Million by 2030, growing at a CAGR of 7.80% during the forecast period. In-vitro fertilization (IVF) has emerged as a crucial assisted reproductive technology for individuals and couples facing fertility challenges. It involves fertilizing eggs with sperm outside the body, with embryos transferred to the uterus after assessment. IVF provides hope to patients with issues such as blocked fallopian tubes, diminished ovarian reserve, or male infertility. India's IVF sector is expanding due to rising infertility rates, growing awareness, and enhanced access to advanced fertility care. Collaborative initiatives like the 2025 partnership between Archish Fertility & IVF and Amaha Health aim to deliver integrated physical and emotional care, further supporting the market's maturity. With greater technological innovation and increasing public acceptance, IVF is increasingly becoming a mainstream fertility solution across urban India.
Key Market Drivers
Growing Success Rate of IVF Technology
The improved success rate of IVF procedures is a primary factor encouraging wider adoption across India. As outcomes have become more reliable and safe, more couples are turning to IVF to address infertility. Innovations in medical protocols, embryo freezing, and hormonal therapies have enhanced success rates and reduced complications. For example, SafeTree’s launch of a dedicated maternity insurance plan for IVF couples in June 2025, which included a reduced waiting period of seven months, reflects growing institutional support for fertility treatments. These advancements reinforce patient confidence and make IVF a more accessible choice for individuals seeking to conceive through assisted reproductive technologies.
Key Market Challenges
Complications Associated with In Vitro Fertilization
Despite increasing demand, IVF procedures are often met with concerns regarding potential health complications. Multiple pregnancies, which may result from transferring more than one embryo, increase the risk of preterm birth and low birth weight. Another common issue is ovarian hyperstimulation syndrome (OHSS), caused by hormone therapy, which can lead to abdominal discomfort, fluid accumulation, or serious health complications. Additionally, the emotional, physical, and financial burdens associated with IVF may deter some individuals from pursuing treatment. These factors necessitate thorough consultation and support to ensure that patients are adequately prepared for the treatment process and its possible outcomes.
Key Market Trends
Increasing Government Support
The Indian government is actively promoting the IVF sector through policy reforms and investment in healthcare infrastructure. The establishment of dedicated fertility centers equipped with modern technologies and skilled specialists is improving access to advanced treatments. Supportive regulations and collaboration with private healthcare players are encouraging domestic and foreign investment in reproductive services. These measures aim to foster innovation, improve affordability, and ensure quality care. As the regulatory environment becomes more favorable, the IVF market in India is evolving into a critical component of the broader reproductive healthcare ecosystem, offering patients more treatment choices and enhanced outcomes.
Key Market Players
• CK Birla Healthcare Pvt. Ltd.
• Nova IVF
• Indira IVF Hospital Private Limited
• Apollo Fertility (Apollo Specialty Hospitals Pvt. Ltd.)
• Max Healthcare
• Manipal Health Enterprises Pvt. Ltd.
• Bloom Fertility Centre
• BACC Healthcare Private Limited
• Cloudnine Hospitals
• Morpheus IVF
• Babies and Us Fertility and IVF Centre (Ind) Pvt. Ltd.
Report Scope:
In this report, the India In-vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• India In-vitro Fertilization Market, By Technique:
o ICSI IVF
o Non-ICSI/ Traditional IVF
• India In-vitro Fertilization Market, By Product:
o IVF Culture Media
o ICSI Machine
o IVF Incubators
o Cryosystem
o Others
• India In-vitro Fertilization Market, By Donor:
o Fresh Non-donor
o Frozen Non-donor
o Fresh Donor
o Frozen Donor
• India In-vitro Fertilization Market, By Infertility:
o Male
o Female
• India In-vitro Fertilization Market, By Embryo:
o Fresh Embryo
o Frozen-thawed Embryo
• India In-vitro Fertilization Market, By End User:
o Fertility Clinics
o Hospitals
o Others
• India In-vitro Fertilization Market, By Region:
o North
o South
o West
o East
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the India In-vitro Fertilization Market.
Available Customizations:
India In-vitro Fertilization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. India In-vitro Fertilization Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technique (ICSI IVF, Non-ICSI/ Traditional IVF)
5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryosystem, Others)
5.2.3. By Donor (Fresh Non-donor, Frozen Non-donor, Fresh Donor, Frozen Donor)
5.2.4. By Infertility (Male, Female)
5.2.5. By Embryo (Fresh Embryo, Frozen-thawed Embryo)
5.2.6. By End User (Fertility Clinics, Hospitals, Others)
5.2.7. By Region (North India, South India, East India, West India)
5.2.8. By Company (2024)
5.3. Market Map
6. North India In-vitro Fertilization Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technique
6.2.2. By Product
6.2.3. By Donor
6.2.4. By Infertility
6.2.5. By Embryo
6.2.6. By End User
7. South India In-vitro Fertilization Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By Product
7.2.3. By Donor
7.2.4. By Infertility
7.2.5. By Embryo
7.2.6. By End User
8. East India In-vitro Fertilization Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By Product
8.2.3. By Donor
8.2.4. By Infertility
8.2.5. By Embryo
8.2.6. By End User
9. West India In-vitro Fertilization Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By Product
9.2.3. By Donor
9.2.4. By Infertility
9.2.5. By Embryo
9.2.6. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. India Economic Profile
13. India In-vitro Fertilization Market: SWOT Analysis
14. Competitive Landscape
14.1. CK Birla Healthcare Pvt. Ltd.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Nova IVF
14.3. Indira IVF Hospital Private Limited.
14.4. Apollo Fertility (Apollo Specialty Hospitals Pvt. Ltd.)
14.5. Max Healthcare
14.6. Manipal Health Enterprises Pvt. Ltd.
14.7. Bloom Fertility Centre
14.8. BACC Healthcare Private Limited
14.9. Cloudnine Hospitals
14.10. Morpheus IVF
14.11. Babies and Us Fertility and IVF Centre (Ind) Pvt. Ltd.
15. Strategic Recommendations
16. About Us & Disclaimer